Back to User profile » Dr Ian Fleming
Paper published by Dr Ian Fleming:
Original Research
KEMTUB012-NI2, a novel potent tubulysin analog that selectively targets hypoxic cancer cells and is potentiated by cytochrome p450 reductase downregulation
Lazzari P, Spiga M, Sani M, Zanda M, Fleming IN
Published Date: 23 May 2017